Psychiatry and Neurology, Epilepsy · Bethesda, MD
NPI
1770528648
Since 2006
Specialty
Psychiatry and Neurology, Epilepsy
Code 2084E0001X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
6410 Rockledge Drive, #610
Bethesda, MD
Phone (301) 530-9744
Groups this clinician bills Medicare through
Medicare paid, 2024
$493K
4,118 services
Medicare patients, 2024
1,479
Average age 75
Drug cost, 2024
$2.2M
3,333 prescriptions
Company payments, 2025
$37K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pavel Klein was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 777 times for 467 patients. In total Pavel Klein billed 4,118 services in 36 codes, and Medicare paid $493K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-18.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 777 | 467 | $14.75 | $11K |
| 99223 Hospital E&M - Initial | Facility | 545 | 514 | $157.25 | $86K |
| 99214 Office E&M - Established | Office | 409 | 275 | $113.04 | $46K |
| 99233 Hospital E&M - Subsequent | Facility | 387 | 218 | $108.56 | $42K |
| 99215 Office E&M - Established | Office | 281 | 162 | $160.68 | $45K |
| 95816 Neurologic | Facility | 269 | 246 | $51.45 | $14K |
| 93042 Electrocardiogram | Facility | 171 | 152 | $6.14 | $1,050 |
| 99291 Critical Care E&M | Facility | 148 | 96 | $194.40 | $29K |
| 99232 Hospital E&M - Subsequent | Facility | 128 | 85 | $72.42 | $9,269 |
| 93040 Electrocardiogram | Office | 102 | 62 | $12.40 | $1,264 |
| 99222 Hospital E&M - Initial | Facility | 99 | 98 | $118.75 | $12K |
| 99205 Office E&M - New | Facility | 79 | 79 | $165.04 | $13K |
| 99205 Office E&M - New | Office | 79 | 78 | $198.64 | $16K |
| 95715 Neurologic | Office | 78 | 36 | $879.71 | $69K |
| 95720 Neurologic | Office | 78 | 36 | $194.17 | $15K |
By year: 2022 $82K for 461 services; 2023 $109K for 589 services; 2024 $493K for 4,118 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pavel Klein prescribed most often to Medicare patients was Lacosamide, with 526 prescriptions and refills. In total Pavel Klein wrote 3,333 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lacosamide Generic | 526 | 662 | 56 | $93K |
| Xcopri Cenobamate | 495 | 529 | 42 | $772K |
| Levetiracetam Generic | 269 | 507 | 53 | $15K |
| Briviact Brivaracetam | 232 | 267 | 27 | $371K |
| Clonazepam Generic | 121 | 139 | 21 | $556 |
| Clobazam Generic | 98 | 130 | 17 | $11K |
| Lamotrigine Generic | 95 | 173 | 16 | $1,589 |
| Amitriptyline Hcl Generic | 79 | 118 | 12 | $866 |
| Quetiapine Fumarate Generic | 74 | 116 | 18 | $1,304 |
| Divalproex Sodium Er Divalproex Sodium | 72 | 100 | Under 11 | $3,758 |
| Divalproex Sodium Generic | 70 | 93 | Under 11 | $2,558 |
| Lamotrigine Er Lamotrigine | 67 | 99 | 11 | $12K |
| Levetiracetam Er Levetiracetam | 66 | 145 | 15 | $5,958 |
| Zonisamide Generic | 61 | 125 | 14 | $2,601 |
| Phenobarbital Generic | 61 | 80 | Under 11 | $1,949 |
Brand drugs: 1,026 claims; generic drugs: 2,246 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pavel Klein $37K ($37K in general payments such as food, travel and fees) from 12 companies. The largest payer was SK Life Science, Inc. with $13K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.